Premium
Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice
Author(s) -
Hawley Sarah T.,
McQueen Amy,
Bartholomew L. Kay,
Greisinger Anthony J.,
Coan Sharon P.,
Myers Ronald,
Ver Sally W.
Publication year - 2011
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.26551
Subject(s) - medicine , concordance , test (biology) , colonoscopy , sigmoidoscopy , fecal occult blood , barium enema , cancer screening , colorectal cancer , family medicine , preference , worry , cancer , gynecology , paleontology , anxiety , psychiatry , economics , biology , microeconomics
BACKGROUND: The purpose of this study was to identify factors associated with colorectal cancer (CRC) screening test preference and examine the association between test preference and test completed. METHODS: Patients (n = 1224) were 50‐70 years, at average CRC risk, and overdue for screening. Outcome variables were preference for fecal occult blood test (FOBT), colonoscopy (COL), sigmoidoscopy (SIG), or barium enema (BE), measured by telephone survey, and concordance between test preference and test completed assessed using medical records. RESULTS: Thirty‐five percent preferred FOBT, 41.1% COL, 12.7% SIG, and 5.7% BE. Preference for SIG or COL was associated with having a physician recommendation, greater screening readiness, test‐specific self‐efficacy, greater CRC worry, and perceived pros of screening. Preference for FOBT was associated with self‐efficacy for doing FOBT. Participants who preferred COL were more likely to complete COL compared with those who preferred another test. Of those screened, only 50% received their preferred test. Those not receiving their preferred test most often received COL (52%). CONCLUSIONS: Lack of concordance between patient preference and test completed suggests that patients' preferences are not well incorporated into screening discussions and test decisions, which could contribute to low screening uptake. Physicians should acknowledge patients' preferences when discussing test options and making recommendations, which may increase patients' receptivity to screening. Cancer 2011. © 2011 American Cancer Society.